1 Drug-Coated Balloons Market Overview
1.1 Product Overview and Scope of Drug-Coated Balloons
1.2 Drug-Coated Balloons Segment by Type
1.2.1 Global Drug-Coated Balloons Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 DCB for Peripheral Artery Disease
1.2.3 DCB for Coronary Artery Disease
1.2.4 DCB for Other Indications
1.3 Drug-Coated Balloons Segment by Application
1.3.1 Drug-Coated Balloons Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Cardiac Catheterization Labs
1.3.4 ASCs
1.4 Global Drug-Coated Balloons Market Size Estimates and Forecasts
1.4.1 Global Drug-Coated Balloons Revenue 2016-2027
1.4.2 Global Drug-Coated Balloons Sales 2016-2027
1.4.3 Drug-Coated Balloons Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drug-Coated Balloons Market Competition by Manufacturers
2.1 Global Drug-Coated Balloons Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug-Coated Balloons Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug-Coated Balloons Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug-Coated Balloons Manufacturing Sites, Area Served, Product Type
2.5 Drug-Coated Balloons Market Competitive Situation and Trends
2.5.1 Drug-Coated Balloons Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug-Coated Balloons Players Market Share by Revenue
2.5.3 Global Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drug-Coated Balloons Retrospective Market Scenario by Region
3.1 Global Drug-Coated Balloons Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug-Coated Balloons Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug-Coated Balloons Market Facts & Figures by Country
3.3.1 North America Drug-Coated Balloons Sales by Country
3.3.2 North America Drug-Coated Balloons Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug-Coated Balloons Market Facts & Figures by Country
3.4.1 Europe Drug-Coated Balloons Sales by Country
3.4.2 Europe Drug-Coated Balloons Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug-Coated Balloons Market Facts & Figures by Region
3.5.1 Asia Pacific Drug-Coated Balloons Sales by Region
3.5.2 Asia Pacific Drug-Coated Balloons Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug-Coated Balloons Market Facts & Figures by Country
3.6.1 Latin America Drug-Coated Balloons Sales by Country
3.6.2 Latin America Drug-Coated Balloons Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug-Coated Balloons Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug-Coated Balloons Sales by Country
3.7.2 Middle East and Africa Drug-Coated Balloons Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drug-Coated Balloons Historic Market Analysis by Type
4.1 Global Drug-Coated Balloons Sales Market Share by Type (2016-2021)
4.2 Global Drug-Coated Balloons Revenue Market Share by Type (2016-2021)
4.3 Global Drug-Coated Balloons Price by Type (2016-2021)

5 Global Drug-Coated Balloons Historic Market Analysis by Application
5.1 Global Drug-Coated Balloons Sales Market Share by Application (2016-2021)
5.2 Global Drug-Coated Balloons Revenue Market Share by Application (2016-2021)
5.3 Global Drug-Coated Balloons Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BD Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 B. Braun Melsungen
6.3.1 B. Braun Melsungen Corporation Information
6.3.2 B. Braun Melsungen Description and Business Overview
6.3.3 B. Braun Melsungen Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B. Braun Melsungen Product Portfolio
6.3.5 B. Braun Melsungen Recent Developments/Updates
6.4 Koninklijke Philips
6.4.1 Koninklijke Philips Corporation Information
6.4.2 Koninklijke Philips Description and Business Overview
6.4.3 Koninklijke Philips Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Koninklijke Philips Product Portfolio
6.4.5 Koninklijke Philips Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boston Scientific Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Opto Circuits (India)
6.6.1 Opto Circuits (India) Corporation Information
6.6.2 Opto Circuits (India) Description and Business Overview
6.6.3 Opto Circuits (India) Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Opto Circuits (India) Product Portfolio
6.6.5 Opto Circuits (India) Recent Developments/Updates
6.7 Acotec Scientific
6.6.1 Acotec Scientific Corporation Information
6.6.2 Acotec Scientific Description and Business Overview
6.6.3 Acotec Scientific Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Acotec Scientific Product Portfolio
6.7.5 Acotec Scientific Recent Developments/Updates
6.8 AR Baltic Medical
6.8.1 AR Baltic Medical Corporation Information
6.8.2 AR Baltic Medical Description and Business Overview
6.8.3 AR Baltic Medical Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.8.4 AR Baltic Medical Product Portfolio
6.8.5 AR Baltic Medical Recent Developments/Updates
6.9 Acrostak
6.9.1 Acrostak Corporation Information
6.9.2 Acrostak Description and Business Overview
6.9.3 Acrostak Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Acrostak Product Portfolio
6.9.5 Acrostak Recent Developments/Updates
6.10 Biosensors International Group
6.10.1 Biosensors International Group Corporation Information
6.10.2 Biosensors International Group Description and Business Overview
6.10.3 Biosensors International Group Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Biosensors International Group Product Portfolio
6.10.5 Biosensors International Group Recent Developments/Updates
6.11 BioMed
6.11.1 BioMed Corporation Information
6.11.2 BioMed Drug-Coated Balloons Description and Business Overview
6.11.3 BioMed Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.11.4 BioMed Product Portfolio
6.11.5 BioMed Recent Developments/Updates
6.12 Concept Medical
6.12.1 Concept Medical Corporation Information
6.12.2 Concept Medical Drug-Coated Balloons Description and Business Overview
6.12.3 Concept Medical Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Concept Medical Product Portfolio
6.12.5 Concept Medical Recent Developments/Updates
6.13 Cardionovum
6.13.1 Cardionovum Corporation Information
6.13.2 Cardionovum Drug-Coated Balloons Description and Business Overview
6.13.3 Cardionovum Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Cardionovum Product Portfolio
6.13.5 Cardionovum Recent Developments/Updates
6.14 Endocor
6.14.1 Endocor Corporation Information
6.14.2 Endocor Drug-Coated Balloons Description and Business Overview
6.14.3 Endocor Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Endocor Product Portfolio
6.14.5 Endocor Recent Developments/Updates
6.15 Hexacath Sverige
6.15.1 Hexacath Sverige Corporation Information
6.15.2 Hexacath Sverige Drug-Coated Balloons Description and Business Overview
6.15.3 Hexacath Sverige Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Hexacath Sverige Product Portfolio
6.15.5 Hexacath Sverige Recent Developments/Updates
6.16 iVascular SLU
6.16.1 iVascular SLU Corporation Information
6.16.2 iVascular SLU Drug-Coated Balloons Description and Business Overview
6.16.3 iVascular SLU Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.16.4 iVascular SLU Product Portfolio
6.16.5 iVascular SLU Recent Developments/Updates
6.17 Minvasys
6.17.1 Minvasys Corporation Information
6.17.2 Minvasys Drug-Coated Balloons Description and Business Overview
6.17.3 Minvasys Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Minvasys Product Portfolio
6.17.5 Minvasys Recent Developments/Updates
6.18 MedAlliance
6.18.1 MedAlliance Corporation Information
6.18.2 MedAlliance Drug-Coated Balloons Description and Business Overview
6.18.3 MedAlliance Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.18.4 MedAlliance Product Portfolio
6.18.5 MedAlliance Recent Developments/Updates
6.19 QT Vascular
6.19.1 QT Vascular Corporation Information
6.19.2 QT Vascular Drug-Coated Balloons Description and Business Overview
6.19.3 QT Vascular Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.19.4 QT Vascular Product Portfolio
6.19.5 QT Vascular Recent Developments/Updates
6.20 RD Global-Invamed
6.20.1 RD Global-Invamed Corporation Information
6.20.2 RD Global-Invamed Drug-Coated Balloons Description and Business Overview
6.20.3 RD Global-Invamed Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.20.4 RD Global-Invamed Product Portfolio
6.20.5 RD Global-Invamed Recent Developments/Updates
6.21 SurModics
6.21.1 SurModics Corporation Information
6.21.2 SurModics Drug-Coated Balloons Description and Business Overview
6.21.3 SurModics Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.21.4 SurModics Product Portfolio
6.21.5 SurModics Recent Developments/Updates
6.22 Terumo
6.22.1 Terumo Corporation Information
6.22.2 Terumo Drug-Coated Balloons Description and Business Overview
6.22.3 Terumo Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Terumo Product Portfolio
6.22.5 Terumo Recent Developments/Updates
6.23 Wellinq
6.23.1 Wellinq Corporation Information
6.23.2 Wellinq Drug-Coated Balloons Description and Business Overview
6.23.3 Wellinq Drug-Coated Balloons Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Wellinq Product Portfolio
6.23.5 Wellinq Recent Developments/Updates

7 Drug-Coated Balloons Manufacturing Cost Analysis
7.1 Drug-Coated Balloons Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug-Coated Balloons
7.4 Drug-Coated Balloons Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug-Coated Balloons Distributors List
8.3 Drug-Coated Balloons Customers

9 Drug-Coated Balloons Market Dynamics
9.1 Drug-Coated Balloons Industry Trends
9.2 Drug-Coated Balloons Growth Drivers
9.3 Drug-Coated Balloons Market Challenges
9.4 Drug-Coated Balloons Market Restraints

10 Global Market Forecast
10.1 Drug-Coated Balloons Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug-Coated Balloons by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug-Coated Balloons by Type (2022-2027)
10.2 Drug-Coated Balloons Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug-Coated Balloons by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug-Coated Balloons by Application (2022-2027)
10.3 Drug-Coated Balloons Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug-Coated Balloons by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug-Coated Balloons by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer